Abstract
Graves' disease (GD) has been reported to be frequently complicated with other autoimmune diseases. However, it is rarely complicated with scleroderma-polymyositis overlap syndrome. Recently, we encountered a 35-year-old woman who developed GD and immune thrombocytopenic purpura during follow-up observation of scleroderma-dermatomyositis overlap syndrome. Platelet counts recovered after high-dose gamma-globulin therapy and bolus methylprednisolone therapy. The present case is the first report of a combination of scleroderma, dermatomyositis, GD, and immune thrombocytopenic purpura. The patient was anti-Ku antibody-positive and had relatively low natural killer T cell counts, both of which might contribute to the complication of multiple autoimmune diseases.
MeSH terms
-
Adult
-
Anti-Inflammatory Agents / therapeutic use
-
Antigens, Nuclear / immunology*
-
Antithyroid Agents / therapeutic use
-
Autoantibodies / blood*
-
DNA Helicases*
-
DNA-Binding Proteins / immunology*
-
Dermatomyositis / complications*
-
Dermatomyositis / drug therapy
-
Dermatomyositis / immunology
-
Female
-
Graves Disease / complications*
-
Graves Disease / drug therapy
-
Graves Disease / immunology
-
Humans
-
Ku Autoantigen
-
Methimazole / therapeutic use
-
Platelet Transfusion
-
Propylthiouracil / therapeutic use
-
Purpura, Thrombocytopenic, Idiopathic / complications*
-
Purpura, Thrombocytopenic, Idiopathic / immunology
-
Purpura, Thrombocytopenic, Idiopathic / therapy
-
Scleroderma, Systemic / complications*
-
Scleroderma, Systemic / drug therapy
-
Scleroderma, Systemic / immunology
-
Steroids
Substances
-
Anti-Inflammatory Agents
-
Antigens, Nuclear
-
Antithyroid Agents
-
Autoantibodies
-
DNA-Binding Proteins
-
Steroids
-
Methimazole
-
Propylthiouracil
-
DNA Helicases
-
XRCC5 protein, human
-
Xrcc6 protein, human
-
Ku Autoantigen